The U.S. Food and Drug Administration (FDA) announced Wednesday that it has received a letter of commitment from Zoetis Animal Health that, by this coming fall, the company will suspend the sale of Histostat (nitarsone)
Continue Reading FDA to Withdraw Approval for Arsenic-Based Drug Used in Poultry